Clinical Trial Update: Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response [Phase 4]

View source ↗

Summary

Phase 4 multicenter trial evaluating a preventive CMV infection strategy in heart transplant patients, focusing on T cell–specific responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cmv Infection
• Heart Transplant Infection

Snippet

Sponsor: Hospital Universitari de Bellvitge | Conditions: Heart Transplant Infection, CMV Infection | Phase 4 | Status: UNKNOWN